rs781048786
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024686.6(TTLL7):c.2026C>G(p.Gln676Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000422 in 1,611,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024686.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151944Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 250092 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1459900Hom.: 0 Cov.: 31 AF XY: 0.0000482 AC XY: 35AN XY: 726262 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151944Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74218 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2026C>G (p.Q676E) alteration is located in exon 17 (coding exon 16) of the TTLL7 gene. This alteration results from a C to G substitution at nucleotide position 2026, causing the glutamine (Q) at amino acid position 676 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at